TIMES OF ISRAEL
by David Shamah
June 19, 2014
The nanotech-based detection system is ready for the market, based on the results of a study by researchers
A cancer-detection technology that “sniffs out” malignant tumors is set to be commercialized, after a study showed that a device based on the Technion-developed “NaNose” system successfully detected lung cancer in patients with up to 90 percent accuracy. At the heart of the device — which looks like a “breathalyzer,” usually used to detect alcohol levels — is a chip based on the NaNose technology developed by a Technion researcher.
By detecting the special “odor” emitted by cancer cells the NaNose system can detect the presence of both benign and malignant tumors much more quickly, efficiently and cheaply, said Dr. Hossam Haick of the Technion, who helped develop the technology. “Current cancer diagnosis techniques are ineffective and impractical.” NaNose technology, he said, “could facilitate faster therapeutic intervention, replacing expensive and time-consuming clinical follow-up that would eventually lead to the same intervention.”
Haick, along with fellow researchers Prof. Nir Peled, of Tel Aviv University’s Sackler Faculty of Medicine, and Prof. Fred Hirsch, of the University of Colorado School of Medicine in Denver, presented the study on the NaNose-based breathalyzer device’s successful cancer detection at a conference in Chicago……
READ MORE
ArchitectGuy on Israel 